Matches in SemOpenAlex for { <https://semopenalex.org/work/W2118562542> ?p ?o ?g. }
- W2118562542 endingPage "2092" @default.
- W2118562542 startingPage "2085" @default.
- W2118562542 abstract "Chronic lymphocytic leukemia (CLL) is clinically heterogeneous. While some patients have indolent disease for many years, 20–30% will progress and ultimately die of their disease. CLL may be classified by the Rai or Binet staging system, mutational status of the immunoglobulin variable heavy-chain gene (IGVH), ZAP-70 overexpression, cytogenetic abnormalities (13q−, + 12, 11q−, 17p−) and expression of several cell surface antigens (CD38, CD49d) that correlate with risk of disease progression. However, none of these markers identify all cases of CLL at risk. In a recent review, we summarized those CD antigens known to correlate with the prognosis of CLL. The present study has identified surface profiles of CD antigens that distinguish clinically progressive CLL from slow-progressive and stable CLL. Using an extended DotScan™ CLL antibody microarray (Version 3; 182 CD antibodies), and with refined analysis of purified CD19 + B-cells, the following 27 CD antigens were differentially abundant for progressive CLL: CD11a, CD11b, CD11c, CD18, CD19, CD20 (two epitopes), CD21, CD22, CD23, CD24, CD25, CD38, CD40, CD43, CD45, CD45RA, CD52, CD69, CD81, CD84, CD98, CD102, CD148, CD180, CD196 and CD270. The extensive surface profiles obtained provide disease signatures with an accuracy of 79.2%, a sensitivity of 83.9% and a specificity of 72.5% that could provide the basis for a rapid test to triage patients with CLL according to probability of clinical progression and potential earlier requirement for treatment." @default.
- W2118562542 created "2016-06-24" @default.
- W2118562542 creator A5004676114 @default.
- W2118562542 creator A5016929277 @default.
- W2118562542 creator A5044944473 @default.
- W2118562542 creator A5050459199 @default.
- W2118562542 creator A5051999274 @default.
- W2118562542 creator A5069975359 @default.
- W2118562542 creator A5072327609 @default.
- W2118562542 creator A5073207811 @default.
- W2118562542 creator A5081516283 @default.
- W2118562542 creator A5087985272 @default.
- W2118562542 date "2014-01-24" @default.
- W2118562542 modified "2023-10-16" @default.
- W2118562542 title "Cell surface phenotype profiles distinguish stable and progressive chronic lymphocytic leukemia" @default.
- W2118562542 cites W115760677 @default.
- W2118562542 cites W1243376384 @default.
- W2118562542 cites W1429374962 @default.
- W2118562542 cites W154103547 @default.
- W2118562542 cites W1551637714 @default.
- W2118562542 cites W1563225271 @default.
- W2118562542 cites W1575383930 @default.
- W2118562542 cites W1581650643 @default.
- W2118562542 cites W1597891616 @default.
- W2118562542 cites W1675877390 @default.
- W2118562542 cites W1844712574 @default.
- W2118562542 cites W189723930 @default.
- W2118562542 cites W1908293564 @default.
- W2118562542 cites W1964264035 @default.
- W2118562542 cites W1964742152 @default.
- W2118562542 cites W1977898643 @default.
- W2118562542 cites W1985159141 @default.
- W2118562542 cites W1990828666 @default.
- W2118562542 cites W1992511689 @default.
- W2118562542 cites W2007573754 @default.
- W2118562542 cites W2015322724 @default.
- W2118562542 cites W2020960488 @default.
- W2118562542 cites W2021533225 @default.
- W2118562542 cites W2025572360 @default.
- W2118562542 cites W2030486864 @default.
- W2118562542 cites W2031567876 @default.
- W2118562542 cites W2034156576 @default.
- W2118562542 cites W2034258866 @default.
- W2118562542 cites W2036435710 @default.
- W2118562542 cites W2041304401 @default.
- W2118562542 cites W2053895312 @default.
- W2118562542 cites W2059413226 @default.
- W2118562542 cites W2061429719 @default.
- W2118562542 cites W2063430427 @default.
- W2118562542 cites W2071698192 @default.
- W2118562542 cites W2071767125 @default.
- W2118562542 cites W2073416029 @default.
- W2118562542 cites W2080166597 @default.
- W2118562542 cites W2081270623 @default.
- W2118562542 cites W2086152189 @default.
- W2118562542 cites W2089670119 @default.
- W2118562542 cites W2090975649 @default.
- W2118562542 cites W2091041184 @default.
- W2118562542 cites W2091417921 @default.
- W2118562542 cites W2107429330 @default.
- W2118562542 cites W2113751763 @default.
- W2118562542 cites W2125647853 @default.
- W2118562542 cites W2131305713 @default.
- W2118562542 cites W2132455828 @default.
- W2118562542 cites W2136628513 @default.
- W2118562542 cites W2141682526 @default.
- W2118562542 cites W2142099365 @default.
- W2118562542 cites W2144851621 @default.
- W2118562542 cites W2146161416 @default.
- W2118562542 cites W2150926065 @default.
- W2118562542 cites W2151970821 @default.
- W2118562542 cites W2154992334 @default.
- W2118562542 cites W2155166310 @default.
- W2118562542 cites W2162167920 @default.
- W2118562542 cites W2171152683 @default.
- W2118562542 cites W2172658766 @default.
- W2118562542 cites W2237362476 @default.
- W2118562542 cites W2247653057 @default.
- W2118562542 cites W2318933236 @default.
- W2118562542 cites W2473568405 @default.
- W2118562542 cites W2571295165 @default.
- W2118562542 doi "https://doi.org/10.3109/10428194.2013.867486" @default.
- W2118562542 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/24289109" @default.
- W2118562542 hasPublicationYear "2014" @default.
- W2118562542 type Work @default.
- W2118562542 sameAs 2118562542 @default.
- W2118562542 citedByCount "27" @default.
- W2118562542 countsByYear W21185625422014 @default.
- W2118562542 countsByYear W21185625422015 @default.
- W2118562542 countsByYear W21185625422016 @default.
- W2118562542 countsByYear W21185625422017 @default.
- W2118562542 countsByYear W21185625422018 @default.
- W2118562542 countsByYear W21185625422019 @default.
- W2118562542 countsByYear W21185625422020 @default.
- W2118562542 countsByYear W21185625422021 @default.
- W2118562542 countsByYear W21185625422022 @default.
- W2118562542 crossrefType "journal-article" @default.
- W2118562542 hasAuthorship W2118562542A5004676114 @default.